[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  WhatMarketMinds [@WhatMarketMind](/creator/twitter/WhatMarketMind) on x 1116 followers Created: 2025-05-05 13:41:21 UTC $GENS 20250424-DBS-Genting Singapore Ltd (GENS) $MLT 20250424-DBS-Mapletree Logistics Trust (MLT) Saving for a rainy day $KEP 20250424-DBS-SG Keppel Ltd (KEP) Stronger_than_expected 1Q25 (KEP) $BBL 20250424-DBS-TH Bangkok Bank (BBL) Weathering near_term turbulence $CZR 20250429-Deutsche Bank-Caesars Entertainment Corporation (CZR) Key Takeaways from Q1'25 Results $AER 20250430-CITI-AerCap (AER) An Attractive Simplicity Focusing on Profitability and Shareholder Ret $AIR 20250430-CITI-Airbus SE (AIR) Q1： 5％ profit beat， but FCF outflow much smaller than expected $ALB 20250430-CITI-Albemarle (ALB) 1Q25 Beat on Input Costs & Productivity； FY25 Guidance Scenarios Un $ALLFG 20250430-CITI-Allfunds (ALLFG) Model Update $6770 20250430-CITI-Alps Alpine (6770) Q4 negative–need to assess impact of reciprocal tariffs $ALSEA 20250430-CITI-Alsea (ALSEA) 1Q25 Results & CC Highlights. Battling Soft Demand and Starbucks Spil $AMGN 20250430-CITI-Amgen Inc. (AMGN) 1Q25 Consensus as of Today $ANTM 20250430-CITI-Aneka Tambang (ANTM) 1Q25–A Strong Beat as Gold and Nickel Are All Firing； Result F $AR 20250430-CITI-Antero Resources (AR) Neutral _ Strong Pricing Continues to Provide Confidence in C $2454 20250430-J.P. Morgan-MediaTek Inc. (2454) First Take： 1Q25 result in line， sluggish 2Q25 and conse $688234 20250430-J.P. Morgan-SICC_A (688234) First Take： 1Q25 results a meaningful miss， reflecting product pr $8035 20250430-J.P. Morgan-Tokyo El_ectron (8035) 4Q results and guidance in line with expectations； no $AIBG 20250501-CITI-AIB Group PLC (AIBG) 1Q25 trading update shows solid operating trends and strong cap $AIBG 20250501-CITI-AIB Group PLC (AIBG) NII waterfall 2025_26E and sensitivities $2802 20250501-CITI-Ajinomoto (2802) Implications from Q1 US hyperscaler results： AI investment still a $MLXS 20250501-J.P. Morgan-Melexis (MLXS) Q1’25 review： Management indicating trough revenues and margin $RIO 20250501-J.P. Morgan-Rio Tinto plc (RIO) What next after dual listing structure is preserved？ Top p $9064 20250501-J.P. Morgan-Yamato Holdings (9064) 4Q results： FY2025 guidance lower than consensus view， $AF 20250502-Bernstein-Air France_KLM (AF) Air France_KLM ： Toujours une hausse des co？ts hors carburan $ABNB 20250502-Bernstein-Airbnb Inc (ABNB) Airbnb 1Q25： Nearing the end of the rainbow $BIIB 20250502-Bernstein-Biogen Inc (BIIB) Biogen 1Q25： Strong Q1 print， but the headline numbers mask US $CI 20250502-Bernstein-Cigna Group (CI) Quick Take： CI 1Q25_Solid beat on better than expected Healthc $ETN 20250502-Bernstein-Eaton Corp PLC (ETN) Quick Take： ETN 1Q25_solid beat； focus on ordersbacklog $H 20250502-Bernstein-Hyatt Hotels Corp (H) Hyatt 1Q25： How great is this Rev_Party？ $ETNB 20250502-Goldman Sachs-89bio Inc. (ETNB) ： 1Q EPS； Ph3 ENLIGHTEN NASH programs are progressing $FOLD 20250502-Goldman Sachs-Amicus Therapeutics Inc. (FOLD) ： 1Q revenue miss； Monitoring PomOp commerc $AJG 20250502-Goldman Sachs-Arthur J. Gallagher & Co. (AJG) 1Q25 EPS Beat on Brokerage Margin & Corpora $BIRG 20250502-Goldman Sachs-Bank of Ireland Group (BIRG) ： Q1’25 IMS $DANSKE 20250502-Goldman Sachs-Danske Bank (DANSKE) ： Q1’25 First Look $FND 20250502-Goldman Sachs-Floor & Decor Holdings (FND) ： Macro environment remains challenging； Manag $2196 20250502-Goldman Sachs-Fosun Pharma (2196) ： Earnings Review： 1Q missed with deeper VBP impacts； p $INGA 20250502-Goldman Sachs-ING Groep NV (INGA) ： Q1’25 First Look $3064 20250502-Goldman Sachs-MonotaRO (3064) Earnings Review： Slightly above expectations on better_than $NWG 20250502-Goldman Sachs-Natwest Group (NWG) ： Q1’25 First Look $688249 20250502-Goldman Sachs-Nexchip (688249) ： 55nm 40nm 28nm in expansion； CIS to drive growth ahead； 1Q $PSON 20250502-Goldman Sachs-Pearson (PSON) ： 1Q25 trading update broadly in line， 2025 outlook reiterate $RBLX 20250502-Goldman Sachs-Roblox (RBLX) ： Q1’25 EPS_First Take $SHEL 20250502-Goldman Sachs-Shell Plc (SHEL) ： Strong results， resilient cash flow and balance sheet. C $WEIR 20250502-Goldman Sachs-Weir Group (WEIR) ： Model adjustments to reflect completion of Micromine acq $ALNY 20250502-UBS-Alnylam Pharmaceuticals Inc (ALNY) 1Q ATTR_CM early launch color highlights robust tre $FOLD 20250502-UBS-Amicus Therapeutics Inc (FOLD) 1Q25 results： PomOp '25 guide lowered but LT on_track， $ASND 20250502-UBS-Ascendis Pharma AS (ASND) Strong 1Q shows accelerating new starts for Yorvipath $AUTOA 20250502-UBS-Auto Trader Plc (AUTOA) AUTO Apr RPI： _despite the political and economic turbulence... $BHVN 20250502-UBS-Biohaven Limited (BHVN) Regulatory pessimism overdone on SCA， representing attractive $BMRN 20250502-UBS-BioMarin Pharmaceutical Inc (BMRN) 1Q25： minimal surprises， potential inflection in gr  XX engagements  **Related Topics** [bbl](/topic/bbl) [coins entertainment](/topic/coins-entertainment) [$czr](/topic/$czr) [bangkok](/topic/bangkok) [saving](/topic/saving) [logistics](/topic/logistics) [$mlt](/topic/$mlt) [gens](/topic/gens) [Post Link](https://x.com/WhatMarketMind/status/1919386938186068114)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
WhatMarketMinds @WhatMarketMind on x 1116 followers
Created: 2025-05-05 13:41:21 UTC
$GENS 20250424-DBS-Genting Singapore Ltd (GENS) $MLT 20250424-DBS-Mapletree Logistics Trust (MLT) Saving for a rainy day $KEP 20250424-DBS-SG Keppel Ltd (KEP) Stronger_than_expected 1Q25 (KEP) $BBL 20250424-DBS-TH Bangkok Bank (BBL) Weathering near_term turbulence $CZR 20250429-Deutsche Bank-Caesars Entertainment Corporation (CZR) Key Takeaways from Q1'25 Results $AER 20250430-CITI-AerCap (AER) An Attractive Simplicity Focusing on Profitability and Shareholder Ret $AIR 20250430-CITI-Airbus SE (AIR) Q1： 5％ profit beat， but FCF outflow much smaller than expected $ALB 20250430-CITI-Albemarle (ALB) 1Q25 Beat on Input Costs & Productivity； FY25 Guidance Scenarios Un $ALLFG 20250430-CITI-Allfunds (ALLFG) Model Update $6770 20250430-CITI-Alps Alpine (6770) Q4 negative–need to assess impact of reciprocal tariffs $ALSEA 20250430-CITI-Alsea (ALSEA) 1Q25 Results & CC Highlights. Battling Soft Demand and Starbucks Spil $AMGN 20250430-CITI-Amgen Inc. (AMGN) 1Q25 Consensus as of Today $ANTM 20250430-CITI-Aneka Tambang (ANTM) 1Q25–A Strong Beat as Gold and Nickel Are All Firing； Result F $AR 20250430-CITI-Antero Resources (AR) Neutral _ Strong Pricing Continues to Provide Confidence in C $2454 20250430-J.P. Morgan-MediaTek Inc. (2454) First Take： 1Q25 result in line， sluggish 2Q25 and conse $688234 20250430-J.P. Morgan-SICC_A (688234) First Take： 1Q25 results a meaningful miss， reflecting product pr $8035 20250430-J.P. Morgan-Tokyo El_ectron (8035) 4Q results and guidance in line with expectations； no $AIBG 20250501-CITI-AIB Group PLC (AIBG) 1Q25 trading update shows solid operating trends and strong cap $AIBG 20250501-CITI-AIB Group PLC (AIBG) NII waterfall 2025_26E and sensitivities $2802 20250501-CITI-Ajinomoto (2802) Implications from Q1 US hyperscaler results： AI investment still a $MLXS 20250501-J.P. Morgan-Melexis (MLXS) Q1’25 review： Management indicating trough revenues and margin $RIO 20250501-J.P. Morgan-Rio Tinto plc (RIO) What next after dual listing structure is preserved？ Top p $9064 20250501-J.P. Morgan-Yamato Holdings (9064) 4Q results： FY2025 guidance lower than consensus view， $AF 20250502-Bernstein-Air France_KLM (AF) Air France_KLM ： Toujours une hausse des co？ts hors carburan $ABNB 20250502-Bernstein-Airbnb Inc (ABNB) Airbnb 1Q25： Nearing the end of the rainbow $BIIB 20250502-Bernstein-Biogen Inc (BIIB) Biogen 1Q25： Strong Q1 print， but the headline numbers mask US $CI 20250502-Bernstein-Cigna Group (CI) Quick Take： CI 1Q25_Solid beat on better than expected Healthc $ETN 20250502-Bernstein-Eaton Corp PLC (ETN) Quick Take： ETN 1Q25_solid beat； focus on ordersbacklog $H 20250502-Bernstein-Hyatt Hotels Corp (H) Hyatt 1Q25： How great is this Rev_Party？ $ETNB 20250502-Goldman Sachs-89bio Inc. (ETNB) ： 1Q EPS； Ph3 ENLIGHTEN NASH programs are progressing $FOLD 20250502-Goldman Sachs-Amicus Therapeutics Inc. (FOLD) ： 1Q revenue miss； Monitoring PomOp commerc $AJG 20250502-Goldman Sachs-Arthur J. Gallagher & Co. (AJG) 1Q25 EPS Beat on Brokerage Margin & Corpora $BIRG 20250502-Goldman Sachs-Bank of Ireland Group (BIRG) ： Q1’25 IMS $DANSKE 20250502-Goldman Sachs-Danske Bank (DANSKE) ： Q1’25 First Look $FND 20250502-Goldman Sachs-Floor & Decor Holdings (FND) ： Macro environment remains challenging； Manag $2196 20250502-Goldman Sachs-Fosun Pharma (2196) ： Earnings Review： 1Q missed with deeper VBP impacts； p $INGA 20250502-Goldman Sachs-ING Groep NV (INGA) ： Q1’25 First Look $3064 20250502-Goldman Sachs-MonotaRO (3064) Earnings Review： Slightly above expectations on better_than $NWG 20250502-Goldman Sachs-Natwest Group (NWG) ： Q1’25 First Look $688249 20250502-Goldman Sachs-Nexchip (688249) ： 55nm 40nm 28nm in expansion； CIS to drive growth ahead； 1Q $PSON 20250502-Goldman Sachs-Pearson (PSON) ： 1Q25 trading update broadly in line， 2025 outlook reiterate $RBLX 20250502-Goldman Sachs-Roblox (RBLX) ： Q1’25 EPS_First Take $SHEL 20250502-Goldman Sachs-Shell Plc (SHEL) ： Strong results， resilient cash flow and balance sheet. C $WEIR 20250502-Goldman Sachs-Weir Group (WEIR) ： Model adjustments to reflect completion of Micromine acq $ALNY 20250502-UBS-Alnylam Pharmaceuticals Inc (ALNY) 1Q ATTR_CM early launch color highlights robust tre $FOLD 20250502-UBS-Amicus Therapeutics Inc (FOLD) 1Q25 results： PomOp '25 guide lowered but LT on_track， $ASND 20250502-UBS-Ascendis Pharma AS (ASND) Strong 1Q shows accelerating new starts for Yorvipath $AUTOA 20250502-UBS-Auto Trader Plc (AUTOA) AUTO Apr RPI： _despite the political and economic turbulence... $BHVN 20250502-UBS-Biohaven Limited (BHVN) Regulatory pessimism overdone on SCA， representing attractive $BMRN 20250502-UBS-BioMarin Pharmaceutical Inc (BMRN) 1Q25： minimal surprises， potential inflection in gr
XX engagements
Related Topics bbl coins entertainment $czr bangkok saving logistics $mlt gens